Stendra (Avanafil): Dosage Information

Dosage Forms and Strengths

STENDRA (avanafil) is available in three different dosage strengths⁚ 50 mg, 100 mg, and 200 mg.​ These dosage forms are supplied as oval, pale yellow tablets.​ Each tablet is debossed with the specific dosage strength to ensure accuracy in administration. The medication is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction in adult males. It is important to follow the recommended starting dose and adjust based on individual efficacy and tolerability.​ The maximum recommended dosing frequency is once per day.​ Storage recommendations include keeping STENDRA at a temperature between 68°F to 77°F and protecting it from light.​

Indications and Usage

STENDRA (avanafil) is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction in adult males.​ The medication is designed to be taken orally as needed, with the recommended starting dose being 100 mg approximately 15 minutes before engaging in sexual activity.​ Based on individual efficacy and tolerability, the dosage may be adjusted to 200 mg taken as early as approximately 15 minutes before sexual activity or decreased to 50 mg taken around 30 minutes before engaging in sexual activity.​ It is essential to note that STENDRA should not be taken more than once a day, and sexual stimulation is necessary for a response to treatment.​

Dosage and Administration

STENDRA (avanafil) should be taken orally as needed for the treatment of erectile dysfunction in adult males.​ The recommended starting dose is 100 mg, to be administered approximately 15 minutes before engaging in sexual activity.​ Depending on individual efficacy and tolerability, the dose can be increased to 200 mg taken around 15 minutes before sexual activity, or decreased to 50 mg taken approximately 30 minutes before sexual activity.​ The maximum recommended dosing frequency is once per day.​ It is crucial to use the lowest effective dose that provides benefit.​ STENDRA can be taken with or without food, and sexual stimulation is required for a response to treatment.

Recommended Starting Dose

For most patients, the starting dose of STENDRA (avanafil) for the treatment of erectile dysfunction is 100 mg.​ This initial dosage should be taken approximately 30 minutes before engaging in sexual activity on an as-needed basis.​ It is crucial not to exceed taking STENDRA more than once per day.​ Depending on individual efficacy and tolerability, the dose may be adjusted.​ This adjustment can involve increasing the dosage to 200 mg or decreasing it to 50 mg, always aiming to utilize the lowest effective dose that provides benefit.​

Individual Efficacy and Tolerability

When considering the efficacy and tolerability of STENDRA (avanafil) for the treatment of erectile dysfunction, it is essential to recognize that individual responses may vary.​ Patients using STENDRA should pay attention to how their body reacts to the medication and communicate any concerns or questions with their healthcare provider.​ The effectiveness of STENDRA can be influenced by factors such as age, underlying health conditions, and concurrent medications being taken.​ Adherence to the recommended dosage and administration instructions is crucial in assessing both the efficacy and tolerability of STENDRA in each individual.​

Maximum Recommended Dosing Frequency

The maximum recommended dosing frequency for STENDRA (avanafil) is once per day.​ It is essential to adhere to this dosing frequency and not exceed taking the medication more than once within a 24-hour period.​ Patients should follow the recommended starting dose and adjust based on individual efficacy and tolerability, ensuring that the lowest effective dose that provides benefit is used.​ Additionally, sexual stimulation is necessary for a response to treatment with STENDRA.​

Administration with or without Food

STENDRA (avanafil) can be taken with or without food.​ The medication is designed to be taken orally as needed for the treatment of erectile dysfunction in adult males. It is recommended to administer STENDRA approximately 15 minutes before engaging in sexual activity.​ Depending on individual efficacy and tolerability, the dosage may be adjusted to optimize the response to treatment.​ Patients must follow the prescribed dosing instructions and not exceed taking STENDRA more than once in a 24-hour period.​ Sexual stimulation is required for STENDRA to be effective.

Contraindications

STENDRA (avanafil) has contraindications that must be carefully considered before use. One of the primary contraindications is the administration of STENDRA with any form of organic nitrates, either regularly or intermittently.​ Patients with conditions such as recent myocardial infarction, stroke, life-threatening arrhythmia, or coronary artery disease should also avoid the use of STENDRA due to potential risks.​ It is crucial to discuss any contraindications with a healthcare provider before starting treatment to ensure the safety and efficacy of the medication.​

Storage Recommendations

It is recommended to store STENDRA (avanafil) at a temperature between 20°C to 25°C (68°F to 77°F).​ Ensure that the medication is kept in a controlled room temperature setting.​ Additionally, it is important to protect STENDRA from light exposure. Following these storage recommendations helps maintain the stability and integrity of the medication for optimal effectiveness.​

Clinical Trial Adverse Reactions

During clinical trials of STENDRA (avanafil), participants were monitored for adverse reactions.​ In various trials lasting up to 3 months, patients were exposed to different dosage strengths of avanafil.​ The most commonly reported adverse reactions included headache, flushing, cold symptoms, back pain, and upper respiratory infections. Less frequent side effects included bronchitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, and rash; It is essential to be aware of these potential reactions and discuss any concerns with a healthcare provider.​

10 responses to “Stendra (Avanafil): Dosage Information”

  1. MedReviewExpert Avatar
    MedReviewExpert

    The clear instructions to follow the recommended starting dose and make adjustments as needed ensure optimal therapeutic outcomes for patients.

  2. Dr. Johnson Avatar
    Dr. Johnson

    The availability of 50 mg, 100 mg, and 200 mg dosage strengths caters to individual patient needs and allows for personalized treatment plans.

  3. PharmD2024 Avatar
    PharmD2024

    The distinct debossing of each tablet with the specific dosage strength enhances safety and reduces the risk of medication errors during administration.

  4. Dr. Patel Avatar
    Dr. Patel

    The debossed dosage strength on each STENDRA tablet facilitates accurate dosing and contributes to the overall safety profile of the medication.

  5. PharmaceuticalCare Avatar
    PharmaceuticalCare

    The dosage forms and strengths of STENDRA provide healthcare providers with options to tailor therapy according to the individual patient

  6. MedicationExpert Avatar
    MedicationExpert

    The supply of STENDRA in tablet form offers convenience in administration and ensures patient compliance with the prescribed treatment regimen.

  7. HealthcarePro Avatar
    HealthcarePro

    STENDRA (avanafil) being a phosphodiesterase 5 (PDE5) inhibitor offers a targeted approach in the management of erectile dysfunction in adult males.

  8. Dr. Smith Avatar
    Dr. Smith

    The variety of dosage strengths available for STENDRA (avanafil) provides flexibility in treatment options for patients with erectile dysfunction.

  9. PharmaSpecialist Avatar
    PharmaSpecialist

    The pale yellow color and oval shape of STENDRA tablets contribute to easy identification and differentiation from other medications.

  10. HealthcarePharmD Avatar
    HealthcarePharmD

    The use of STENDRA (avanafil) as a treatment for erectile dysfunction underscores the importance of addressing this condition in adult male patients.

Leave a Reply

Your email address will not be published. Required fields are marked *